Using BRAFV600E melanoma lines and BRAF inhibitors, Caramel et al., demonstrated that the ZEB switch described above, can be initiated and sustained by MAPK/ERK signaling through FRA-1, an ERK-regulated component of the AP-1 complex. Here, BRAF is linked to melanoma.